Looking for a NEW AUCTION Venue? Try BidJit.com for 30 Days for FREE! - Sponsored AD

Home
Blogs
Videos
- New Videos
- Most Popular
- Most Views
- Upload Video |

News

Entertainment

Business

FDA Launches Safety Review of Two Antirejection Agents

Published: April 11, 2008, 3:05 pm

ROCKVILLE, Md. -- The FDA announced a safety review of mycophenolate mofetil (CellCept) and mycophenolic acid (Myfortic) following reports of a possible link to progressive multifocal leukoencephalopathy.

[ Full article ]

Blog link

Rating: 0

Comments

Leave a comment.

No Comments...

Related Videos
Related Posts
1. Welch calls for safety review of aging nuclear reactors
  U.S. Rep. Peter Welch has joined U.S. Sen. Bernie Sanders...
2. Welch calls for safety review of aging nuclear reactors
  U.S. Rep. Peter Welch has joined U.S. Sen. Bernie Sanders...
3. FDA Launches Safety Review of Two Antirejection Agents
  ROCKVILLE, Md. -- The FDA announced a safety review of...
4. Pediatric Cancer Cases Trigger FDA Safety Review of TNF Blockers
  ROCKVILLE -- The FDA said today it is investigating a...
5. FDA Starts Safety Review of Autoimmune Disorder Drugs - Washington Post
  Enews 2.0FDA Starts Safety Review of Autoimmune Disorder...
6. FDA Starts Safety Review of Autoimmune Disorder Drugs
  Title: FDA Starts Safety Review of Autoimmune Disorder...